Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Royalty Pharma (RPRX)

  • Event
  • May 11, 2022, 15:32 UTC
  • 19
  • 1 comments

(99% Neutral) Royalty Pharma plc (RPRX) Announces Business Combination

Comment Full text

Genmab (GMAB)

  • Event
  • May 11, 2022, 15:24 UTC
  • 10
  • 1 comments

(30% Negative) Genmab (GMAB) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text

RedHill Biopharma (RDHL)

  • Event
  • May 11, 2022, 12:56 UTC
  • 11
  • 1 comments

(99% Neutral) RedHill Biopharma (RDHL) Files Form 6-K

Comment Full text

Absci Corporation (ABSI)

  • Event
  • May 11, 2022, 12:15 UTC
  • 15
  • 1 comments

(30% Negative) ABSCI CORP (ABSI) Reports Q2 2022 Financial Results

Comment Full text

Ovid Therapeutics Inc (OVID)

  • Event
  • May 11, 2022, 12:13 UTC
  • 18
  • 1 comments

(10% Negative) OVID THERAPEUTICS INC. (OVID) Announces Clinical Trial Timeline Adjustment

Comment Full text

RAPT Therapeutics Inc (RAPT)

  • Event
  • May 11, 2022, 12:10 UTC
  • 21
  • 1 comments

(99% Positive tone) RAPT Therapeutics, Inc. (RAPT) Reports Q2 2022 Financial Results

Comment Full text

Moderna Inc (MRNA)

  • Event
  • May 11, 2022, 12:01 UTC
  • 14
  • 1 comments

(99% Neutral tone) MODERNA, INC. (MRNA) Announces Executive Departure

Comment Full text

Edgewise Therapeutics Inc (EWTX)

  • Event
  • May 11, 2022, 12:00 UTC
  • 14
  • 1 comments

(99% Positive tone) Edgewise Therapeutics, Inc. (EWTX) Reports Q2 2022 Financial Results

Comment Full text

Monte Rosa Therapeutics (GLUE)

  • Event
  • May 11, 2022, 11:38 UTC
  • 21
  • 1 comments

(99% Neutral tone) MONTE ROSA THERAPEUTICS, INC. (GLUE) Reports Q2 2022 Financial Results

Comment Full text

KAMADA (KMDA)

  • Event
  • May 11, 2022, 11:00 UTC
  • 11
  • 1 comments

(99% Neutral) KAMADA (KMDA) Announces Clinical Development Update (Form 6-K)

Comment Full text
  • Previous
  • 227
  • 228
  • 229
  • 230
  • 231
  • Next

Search

News categories

  • Technical Exchange News(10896)
  • Event(2301)
  • SEC News(190142)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124799)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin